ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 140 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2018. The put-call ratio across all filers is 1.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $55,000 | -30.4% | 30,000 | 0.0% | 0.01% | -31.6% |
| Q2 2021 | $79,000 | -37.3% | 30,000 | -14.3% | 0.02% | -42.4% |
| Q1 2021 | $126,000 | -43.5% | 35,000 | -60.5% | 0.03% | -52.9% |
| Q4 2020 | $223,000 | -69.4% | 88,525 | -69.4% | 0.07% | -73.6% |
| Q3 2020 | $728,000 | -4.1% | 289,025 | +24.6% | 0.26% | -7.0% |
| Q2 2020 | $759,000 | +34.3% | 232,025 | +0.7% | 0.28% | +9.6% |
| Q1 2020 | $565,000 | -75.4% | 230,525 | -52.6% | 0.26% | -39.4% |
| Q4 2019 | $2,294,000 | +122.5% | 486,050 | +101.8% | 0.43% | -7.3% |
| Q3 2019 | $1,031,000 | -18.5% | 240,800 | +11.0% | 0.46% | -19.9% |
| Q2 2019 | $1,265,000 | +64.3% | 216,950 | +8.5% | 0.58% | +55.8% |
| Q1 2019 | $770,000 | +118.1% | 199,950 | +5.8% | 0.37% | +71.0% |
| Q4 2018 | $353,000 | – | 188,950 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,642,959 | $25,186,000 | 3.76% |
| MSD Partners, L.P. | 15,151,516 | $26,061,000 | 2.11% |
| MSD Partners, L.P. | 7,575,758 | $13,030,000 | 1.05% |
| MAGNOLIA CAPITAL ADVISORS LLC | 418,569 | $720,000 | 0.61% |
| STEEL GROVE CAPITAL ADVISORS, LLC | 1,080,000 | $1,858,000 | 0.33% |
| EAM Investors, LLC | 454,625 | $782,000 | 0.17% |
| Allred Capital Management, LLC | 158,000 | $271,000 | 0.17% |
| Boxer Capital, LLC | 1,500,000 | $2,580,000 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 608,037 | $1,046,000 | 0.14% |
| CHIRON CAPITAL MANAGEMENT, LLC | 116,860 | $201,000 | 0.14% |